CytRx (CYTR) Reports Removal of FDA Partial Clinical Hold on Aldoxorubicin Tests
Tweet Send to a Friend
CytRx (NASDAQ: CYTR) announced that the United States Food and Drug Administration (FDA) has removed the partial clinical hold on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
